Hunan Er Kang Pharmaceutical (300267) — Cash Flow Reinvestment Rate
Hunan Er Kang Pharmaceutical (300267) has a Cash Flow Reinvestment Rate of 0.46x as of June 2023, reinvesting CN¥80.56 Million (capex CN¥45.68 Million plus investments CN¥34.88 Million) from operating cash flow of CN¥174.55 Million. Check 300267 operating cash flow to net income to evaluate the quality of earnings relative to operating cash generation.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hunan Er Kang Pharmaceutical Cash Flow Reinvestment Rate (2008–2024)
Historical reinvestment intensity for Hunan Er Kang Pharmaceutical across 17 annual periods. Explore 300267 cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.
Annual Cash Flow Reinvestment Rate for Hunan Er Kang Pharmaceutical (2008–2024)
Year-by-year capital reinvestment analysis for Hunan Er Kang Pharmaceutical. For live market cap and broader valuation context, see how much is Hunan Er Kang Pharmaceutical worth.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2024 | 3.11x | CN¥517.75 Million | CN¥166.69 Million | CN¥195.60 Million | ▲ +34.4% |
| 2023 | 2.31x | CN¥343.11 Million | CN¥148.42 Million | CN¥238.19 Million | ▲ +137.5% |
| 2022 | 0.97x | CN¥273.49 Million | CN¥281.02 Million | CN¥173.49 Million | ▼ -87.2% |
| 2021 | 7.60x | CN¥704.27 Million | CN¥92.68 Million | CN¥349.33 Million | ▲ +27.7% |
| 2020 | 5.95x | CN¥1.06 Billion | CN¥178.53 Million | CN¥605.89 Million | ▲ +431.5% |
| 2019 | 1.12x | CN¥498.88 Million | CN¥445.82 Million | CN¥364.21 Million | ▼ -40.1% |
| 2018 | 1.87x | CN¥231.39 Million | CN¥123.89 Million | CN¥96.72 Million | ▲ +269.0% |
| 2017 | 0.51x | CN¥348.81 Million | CN¥689.11 Million | CN¥258.92 Million | ▼ -80.8% |
| 2016 | 2.64x | CN¥1.29 Billion | CN¥486.50 Million | CN¥1.15 Billion | ▲ +140.4% |
| 2015 | 1.10x | CN¥570.53 Million | CN¥518.96 Million | CN¥570.53 Million | ▼ -63.4% |
| 2014 | 3.01x | CN¥527.42 Million | CN¥175.38 Million | CN¥527.42 Million | ▲ +156.9% |
| 2013 | 1.17x | CN¥203.98 Million | CN¥174.22 Million | CN¥203.98 Million | ▼ -57.5% |
| 2012 | 2.75x | CN¥231.28 Million | CN¥84.02 Million | CN¥231.28 Million | ▲ +375.1% |
| 2011 | 0.58x | CN¥43.87 Million | CN¥75.72 Million | CN¥43.87 Million | ▼ -62.2% |
| 2010 | 1.53x | CN¥65.05 Million | CN¥42.47 Million | CN¥65.05 Million | ▼ -20.6% |
| 2009 | 1.93x | CN¥19.64 Million | CN¥10.18 Million | CN¥19.64 Million | ▼ -96.8% |
| 2008 | 59.81x | CN¥12.62 Million | CN¥211.00K | CN¥12.62 Million | — |